Investing in dividend-paying stocks is one of numerous approaches that can help you maximize your portfolio growth, and ...

Diseases and disorders particularly that of bowels and digestive process is more common than others and colitis is one such common disease that is experienced by countless people all over the world.

PALI-2108 is the first and only PDE4 inhibitor in development targeting the terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Psychologist Melissa Hunt and gastroenterologist Chung Sang Tse and colleagues have found that cognitive behavioral therapy ...

The ulcerative colitis market is experiencing steady growth driven by rising disease prevalence and increasing diagnosis rates worldwide. Expanding adoption of advanced biologics, small-molecule ...

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight The ulcerative colitis market is ...

Ulcerative Colitis Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key ...

DelveInsight's Ulcerative Colitis Market Insights report includes a comprehensive understanding of current treatment practices, ulcerative colitis emerging drugs, market share of individual therapies, ...

Lymphocytic colitis is a bowel condition characterized by chronic, watery diarrhea and the buildup of white blood cells in your gut. It is most common in older adults. Lymphocytic colitis is a rare ...